DH
Therapeutic Areas
Elephas Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| elive™ Platform Validation | Multiple Solid Tumors (NSCLC, Bladder, Colorectal, etc.) | Observational Trials |
| ELEPHAS-01 (Lung Trial) | Metastatic/Recurrent Non-Small Cell Lung Cancer | Observational |
| ELEPHAS-02 (Basket Trial) | Multiple Metastatic/Advanced Solid Tumors | Observational |
| ELEPHAS-04 (Mayo Clinic) | Multiple Solid Tumors | Observational |